Clinician Assessed Versus Objective Measures of Frailty in Left Ventricular Assist Device Patients
Recommended Citation
Steinberg RS, Cowger JA, Hsi B, Morris A, Nohria A, Hall S, Nayak A. Clinician Assessed Versus Objective Measures of Frailty in Left Ventricular Assist Device Patients. J Heart Lung Transplant 2024; 43(4):S500-S501.
Document Type
Conference Proceeding
Publication Date
4-1-2024
Publication Title
J Heart Lung Transplant
Abstract
Purpose: Society guidelines recommend frailty assessment in Left Ventricular Assist Device (LVAD) candidates. Frailty is a multi-domain syndrome that includes compromised mobility and nutritional status. While often assessed via the “eyeball test,” there is a need to identify objective frailty measures that correlate with patient outcomes, allowing for standardization of candidacy assessment. We studied 1) the association of clinician assessed frailty with objective measures of mobility (6-minute walk distance, 6MWD) and nutritional status (prealbumin), and 2) the association of these factors with outcomes. Methods: We included LVAD patients from 2007-17 from the Intermacs registry who had frailty status reported. Objective frailty measures were compared between patients with and without clinician assessed frailty. Multivariable models were used to study the association between objective frailty measures and post-LVAD mortality. The association of clinician assessed frailty with mortality was studied via a propensity score-matched analysis, matching for disease severity and objective frailty measures. Results: Of 15,371 patients (age: 56.9 13.0 yrs, 21% female, 24% Black), 1015 (6.6%) were clinician assessed as frail. Clinician assessed frailty correlated with objective frailty measures. (Table 1) Patients too sick to complete testing or those with 6MWD <300 m, and prealbumin<16 mg/dL had significantly worse mortality than those with values above these thresholds, independent of clinician assessed frailty. (Table 2) Clinician assessed frailty remained associated with mortality in the propensity-matched analysis (n=932, HR: 1.25 [1.01-1.55], p=0.04). Conclusion: In this analysis, we demonstrate that routinely obtained, objective measures of frailty can be used to identify patients at risk for increased events after LVAD. Utilization of objective measures may allow for improved frailty comparisons over time, between centers, and amongst different patient populations. [Formula presented]
Volume
43
Issue
4
First Page
S500
Last Page
S501